Axonis Logo
  • About Us
    • Our Mission
    • Key Personnel
      • Corey S. Goodman, Ph.D.
      • Joanna Stanicka, Ph.D.
      • Shane V. Hegarty, Ph.D.
      • Bob Yant
      • Jeff Stevens
      • Richard A. Sipos
      • Brock Reeve, M.Phil., M.B.A.
      • Oswald Steward, Ph.D.
      • Lisa McKerracher, Ph.D.
      • Clifford Woolf, PH.D
      • James Guest, MD, PH.D, FACS
  • News
  • Our Science
    • Our Approach
    • KCC2 Potentiation
    • Neuroprotection
  • Contact Us

Reviving Neurons - Restoring Control Read More > AXONIS Therapeutics is advancing breakthrough discoveries to develop first-in-class therapies Read More > for neurological disorders
SHARE:
  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • About Us
    • Our Mission
    • Key Personnel
      • Corey S. Goodman, Ph.D.
      • Joanna Stanicka, Ph.D.
      • Shane V. Hegarty, Ph.D.
      • Bob Yant
      • Jeff Stevens
      • Richard A. Sipos
      • Brock Reeve, M.Phil., M.B.A.
      • Oswald Steward, Ph.D.
      • Lisa McKerracher, Ph.D.
      • Clifford Woolf, PH.D
      • James Guest, MD, PH.D, FACS
  • News
  • Our Science
    • Our Approach
    • KCC2 Potentiation
    • Neuroprotection
  • Contact Us

FCOI Policy

© 2022 Axonis. All rights reserved. | Website: David Kerr Design

Axonis Home
  • About Us
    ▼
    • Our Mission
    • Key Personnel
      ▼
      • Corey S. Goodman, Ph.D.
      • Joanna Stanicka, Ph.D.
      • Shane V. Hegarty, Ph.D.
      • Bob Yant
      • Jeff Stevens
      • Richard A. Sipos
      • Brock Reeve, M.Phil., M.B.A.
      • Oswald Steward, Ph.D.
      • Lisa McKerracher, Ph.D.
      • Clifford Woolf, PH.D
      • James Guest, MD, PH.D, FACS
  • News
  • Our Science
    ▼
    • Our Approach
    • KCC2 Potentiation
    • Neuroprotection
  • Contact Us
Scroll Up